TROCHLEAR DYSPLASIA

This adverse event was reported 3 times

TROCHLEAR DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AUTOLOGOUS CULTURED CHONDROCYTES 1 0.0022
1 PHYTONADIONE 1 0.0001
2 METHOCARBAMOL TABLETS 1 0.0001
3 VALPROATE SODIUM 1 0.0000
4 METHOCARBAMOL 1 0.0000
5 PAROXETINE HYDROCHLORIDE HEMIHYDRATE 1 0.0000
6 DOCUSATE SODIUM 1 0.0000
7 RISANKIZUMAB-RZAA 1 0.0000
8 PAROXETINE HYDROCHLORIDE 1 0.0000
9 NAPROXEN SODIUM 1 0.0000
See all drugs enriched for association with TROCHLEAR DYSPLASIA

TROCHLEAR DYSPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Autologous Cultured Cell [EPC] 1 0.0022
1 Vitamin K [EPC] 1 0.0001
2 Muscle Relaxant [EPC] 1 0.0000
3 Interleukin-23 Antagonist [EPC] 1 0.0000
4 Vitamin D [EPC] 1 0.0000
5 Vitamin B12 [EPC] 1 0.0000
6 Vitamin C [EPC] 1 0.0000
7 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with TROCHLEAR DYSPLASIA